This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a hepatitis B vaccine. The fixed-price contract has a ceiling value of $1,631.24 and an ultimate completion date of December 5, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated with any set-aside requirements, indicating open competition. The contract aligns with the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces, various federal agencies, and partner nations.
Generated 3/5/25, 9:46 AM